Robert Iannone - 27 Aug 2026 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Reporting relationship: EVP, Global Head of R&D & CMO
Issuer ticker: JAZZ
Reported as of: 27 Aug 2026
Net transaction value: -$19,207,098
SEC form: 4
Accepted by SEC: 31 Aug 2026, 18:45:25 UTC
Prior SEC filing: 13 Jul 2026
Source filing: View source filing
Reporting owner signature: By: /s/Paz Dizon, as attorney in fact For: Robert Iannone

Key filing fact

Robert Iannone filed Form 4 for Jazz Pharmaceuticals plc (JAZZ) on 31 Aug 2026.

Key facts

This page summarizes Robert Iannone's Form 4 filing for Jazz Pharmaceuticals plc (JAZZ).
14 reported transactions and 4 derivative rows are listed below.
Accepted by SEC: 31 Aug 2026, 18:45.

Change

Previous filing in this sequence was filed on 13 Jul 2026.
Current net transaction value: -$19,207,098.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001737329 Primary reporting owner

Iannone Robert

Relationship: EVP, Global Head of R&D & CMO
Address: 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN 4, IRELAND
Signature: By: /s/Paz Dizon, as attorney in fact For: Robert Iannone
Signature date: 31 Aug 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +26,116
Change %: +31%
Price: $113.10^*
Shares after: 111,223
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +884
Change %: +0.79%
Price: $113.10^*
Shares after: 112,107
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +27,584
Change %: +25%
Price: $137.12^*
Shares after: 139,691
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Options Exercise

Transaction value
Shares: +2,916
Change %: +2.1%
Price: $137.12^*
Shares after: 142,607
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $4,507,781
Shares: -18,187
Change %: -13%
Price: $247.86
Shares after: 124,420
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F2

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $2,840,516
Shares: -11,423
Change %: -9.2%
Price: $248.67
Shares after: 112,997
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F3

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $4,528,572
Shares: -18,113
Change %: -16%
Price: $250.02
Shares after: 94,884
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F4

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $4,921,596
Shares: -19,639
Change %: -21%
Price: $250.60
Shares after: 75,245
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F5

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $2,332,804
Shares: -9,259
Change %: -12%
Price: $251.95
Shares after: 65,986
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1, F6

JAZZ transaction

Ordinary Shares

Sale

Transaction value: $75,828
Shares: -300
Change %: -0.45%
Price: $252.76
Shares after: 65,686
Date: 27 Aug 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JAZZ transaction Derivative

Incentive Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -884
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 884
Exercise price: $113.10
Footnotes: F1, F7

JAZZ transaction Derivative

Incentive Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -2,916
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 2,916
Exercise price: $137.12
Footnotes: F1, F8

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -26,116
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 26,116
Exercise price: $113.10
Footnotes: F1, F7

JAZZ transaction Derivative

Non-Qualified Stock Option (right to buy)

Options Exercise

Transaction value
Shares: -27,584
Change %: -100%
Price: $0.000000^*
Shares after: 0
Date: 27 Aug 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 27,584
Exercise price: $137.12
Footnotes: F1, F8

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 8 footnotes

Footnote F1

This transaction was made pursuant to a plan adopted by the reporting person on May 28, 2026 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended. The transaction occurred automatically and does not represent a discretionary transaction by the reporting person.

Footnote F2

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $247.29 to $248.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F3

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $248.29 to $249.24. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F4

Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $249.33 to $250.325 The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F5

Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $250.33 to $251.29. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F6

Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $251.37 to $252.31. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected.

Footnote F7

These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.

Footnote F8

These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the vesting commencement date of May 29, 2019, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in 36 equal monthly installments thereafter.